z-logo
Premium
Digoxin‐verapamil interaction: Reduction of biliary but not renal digoxin clearance in humans
Author(s) -
Hedman Ann,
Angelin Bo,
Arvidsson Annie,
Beck Olof,
Dahlqvist Rune,
Nilsson Bengt,
Olsson Margareta,
SchenckGustafsson Karin
Publication year - 1991
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.1991.26
Subject(s) - digoxin , verapamil , medicine , drug interaction , endocrinology , clearance , renal function , pharmacokinetics , pharmacology , chemistry , urology , calcium , heart failure
The interaction between digoxin and verapamil was studied in six patients (mean age ± SD, 61 ± 5 years) with chronic atrial fibrillation. The effects of adding verapamil (240 mg/day) on steady‐state plasma concentrations and renal and biliary clearances of digoxin were studied in a crossover manner. The biliary clearance of digoxin was determined by a duodenal perfusion technique. Verapamil induced a 44% increase in steady‐state plasma concentrations of digoxin, from 0.80 ± 0.24 to 1.15 ± 0.40 nmol/L (p < 0.01). The biliary clearance of digoxin decreased by 43%, from 187 ± 89 to 101 ± 55 ml/min (p < 0.05), in the presence of verapamil, whereas the renal clearance was unaffected (153 ±31 versus 173 ± 51 ml/min; difference not significant). Our results indicate that the main inhibitory effect of verapamil on digoxin elimination is on the biliary route. Clinical Pharmacology and Therapeutics (1991) 49, 256–262; doi: 10.1038/clpt.1991.26

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom